Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

Famed Cancer Researcher Folkman Dies

Source: ap.google.com
Eric WhitmanJanuary 23, 2008
Judah Folkman was an amazing and inspirational medical pioneer
Author: Eric Whitman, MD, Medical Director, Office of Grants and Research, Atlantic Health System Inc
The medical and scientific worlds lost a great man when Dr. Judah Folkman recently passed away. His work in anti-angiogenesis was very inspiring and created a whole new area of scientific research to fight cancer, which eventually led to new drugs and treatments, principally Avastin. Dr. Folkman was able to combine surgical expertise with research innovation. He adapted to the changing scientific...
January 21, 2008
Dr. Folkman : apioneer in the fiels of anti-angiogenesis, but the anti-cancer battle still NOT won
Author: GLG Expert Contributor
Dr. Folkman first prposed that targeting anti-angiogenesis in an article in 1971. Genentech's antiangiogenesis drug , Avastin is a block buster and has had modest succeses in treatment of advanced colorectal ,breast, and renal cancer. Angiogenesis is only one pathway involved in cancer development and cancer cell survival, so to really beat cancer is by combining classic cyttoxic chemotherapy...
Jeff StierJanuary 17, 2008
Lessons Learned from The Dr. Folkman "Controversies"
Author: Jeff Stier, Associate Director, American Council on Science and Health
These lessons are valuable for considering new cancer research findings.     Just ask Genentech. Symbol: DNA

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-11-21T13:45:47.600